Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development
Abstract Background Although mRNA vaccines have been effective against multiple cancers, their efficacy against pancreatic adenocarcinoma (PAAD) remains undefined. Accumulating evidence suggests that immunotyping can indicate the comprehensive immune status in tumors and their immune microenvironmen...
Main Authors: | Xing Huang, Gang Zhang, Tianyu Tang, Tingbo Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-021-01310-0 |
Similar Items
-
Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
by: Xing Huang, et al.
Published: (2021-03-01) -
Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
by: Hua Zhong, et al.
Published: (2021-08-01) -
Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
by: Shuai Ma, et al.
Published: (2021-09-01) -
Immune Gene Signatures and Immunotypes in Immune Microenvironment Are Associated With Glioma Prognose
by: Cao, H., et al.
Published: (2022) -
Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes
by: Willem de Koning, et al.
Published: (2021-04-01)